Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Melanoma 21Neoplasms 6Carcinoma, Hepatocellular 5Stomach Neoplasms 4Recurrence 4Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Advanced Cancer 4Uveal Melanoma 3Urinary Bladder Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Liver Neoplasms 3Colonic Neoplasms 3Rectal Neoplasms 2Ovarian Neoplasms 2Neoplasms by Site 2Neoplasm Metastasis 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Hodgkin Disease 2Hematologic Neoplasms 2Glioma 2Glioblastoma 2Esophageal Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Renal Cell 2Carcinoma, Basal Cell 2Brain Neoplasms 2

Interventions

Nivolumab 6Imatinib Mesylate 4Ipilimumab 3Cetuximab 3pembrolizumab 2palbociclib 2Specimen Handling 2Radiotherapy 2Radiosurgery 2Protons 2Proton Therapy 2Pemetrexed 2Magnetic Resonance Spectroscopy 2Cyclophosphamide 2tazemetostat 1spartalizumab 1relatlimab 1nilotinib 1camrelizumab 1avelumab 1atezolizumab 1apatinib 1Zoledronic Acid 1X-Rays 1Tiragolumab 1Thiotepa 1Radiotherapy, Intensity-Modulated 1Radiation 1Photochemotherapy 1Phantoms, Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Chordoma × relatlimab × Clear all
NCT03623854 2024-04-16

Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma

Jonsson Comprehensive Cancer Center

Phase 2 Completed
10 enrolled
Sarcoma

Chordoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡